This column first appeared on Real Money on Sept. 27 at 4.37 p.m. EST.
NEW YORK ( TheStreet) -- Memo to Herb Greenberg: Do not read this column because my motto is "if you can't beat 'em, join 'em."
Go buy some Celgene (CELG - Get Report), Biogen (BIIB - Get Report), Regeneron (REGN - Get Report) and Gilead (GILD - Get Report).Scoop up some Netflix (NFLX), Tesla (TSLA) and Amazon (AMZN). Get comfy with LinkedIn (LNKD). Explore the possibility of Priceline.com (PCLN), and, yes, join Facebook (FB).
Do it all with deep-in-the-money calls. You will get a chance in the next few days as the government shutdown comes.These are, as I have said here often, the anointed stocks. These are the ones the institutions own. I used to be like Herb. I saw it for what it was, what they are doing, just like Herb does. It's transparent. It mocks the process. But they don't make it hard, Herb. They make it easy. They leave footprints everywhere. They don't disguise their buying. And we know as the quarter comes to a close that these stocks will be loved and bid for during every decline. Others are being eyed for anointment. Chipotle's (CMG) stock has given off the aura. So has Starbucks (SBUX). You can sense that the heavyweight momentum players aren't ever going to get enough of Salesforce.com (CRM). Can you see the love, Herb, for Tractor Supply (TSCO) and Lumber Liquidators (LL - Get Report)? Now we know that this game ends and Herb gets to be right a la Intuitive Surgical (ISRG). But I do not think he can be right for the rest of 2013. There's too much momentum here. So, I am sorry Herb. But the cult of anointment only grows stronger in the fourth quarter. Don't you just hate me? Ha, you did read it. Told ya not to. Written by Jim Cramer Action Alerts PLUS, which Cramer co-manages as a charitable trust, is long FB.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts